Image may be NSFW.
Clik here to view.
Clik here to view.
NasVax antibody data published in PLOS ONE
An article describing a new mechanism of action of NasVax’s (TASE:NSVX) novel immunotherapeutic BBS monoclonal antibody (MAb) for Alzheimer’s disease has been published in the peer-reviewed journal...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Leerink starts MacroGenics at outperform
Leerink Swann has initiated coverage of MacroGenics (NASDAQ:MGNX) with an “outperform” rating and price target of $34. The stock closed at $27.22 on Friday. MacroGenics is focused on developing new...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
HCW resumes coverage of TG Therapeutics at buy
H.C. Wainwright has resumed coverage of TG Therapeutics (NASDAQ:TGTX) with a “buy” rating and $22 price target. The stock closed at $16.11 on Tuesday. “With so much of the general early-stage...
View Article
More Pages to Explore .....
